Familial nonmedullary thyroid carcinoma

Thyroid

Volumn 23, Issue 9, 2013, Pages 1049-1056

  Mazeh, Haggi ^a,b   Sippel, Rebecca S ^a  

^a University of Wisconsin Health   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE PREDISPOSITION; ECHOGRAPHY; FAMILIAL DISEASE; FAMILIAL NONMEDULLARY THYROID CARCINOMA; FINE NEEDLE ASPIRATION BIOPSY; GENETIC HETEROGENEITY; HUMAN; LYMPH NODE; OVERALL SURVIVAL; PATHOGENESIS; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; THYROID CARCINOMA; THYROIDECTOMY; TUMOR INVASION; ADENOCARCINOMA, FOLLICULAR; CARCINOMA; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION; GENETICS; HEREDITY; INCIDENCE; MORTALITY; PATHOLOGY; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; THYROID NEOPLASMS; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; INCIDENCE; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84884130426     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0079     Document Type: Review

References (57)

1. SEER stat fact sheets: Thyroid. http://seer.cancer.gov/statfacts/html/ thyro.html (last accessed on June 12, 2012).
2. Siegel R, Naishadham D, Jemal A 2012 Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
3. Malchoff CD, Malchoff DM 2006 Familial nonmedullary thyroid carcinoma. Cancer Control 13:106-110.
4. Caron NR, Clark OH 2006 Papillary thyroid cancer. Curr Treat Options Oncol 7:309-319.
5. LiVolsi VA 2011 Papillary thyroid carcinoma: an update. Mod Pathol 24 Suppl 2:S1-S9.
6. Bonora E, Tallini G, Romeo G 2010 Genetic predisposition to familial nonmedullary thyroid cancer: an update of molec-ular findings and state-of-the-art studies. J Oncol 2010:385206.
7. Sippel RS, Caron NR, Clark OH 2007 An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924-933.
8. Sturgeon C, Clark OH 2005 Familial nonmedullary thyroid cancer. Thyroid 15:588-593.
9. Robinson D, Orr T 1955 Carcinoma of the thyroid and other diseases of the thyroid in identical twins. AMA Arch Surg 70:923-928.
10. Vriens MR, Suh I, Moses W, Kebebew E 2009 Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 19:1343-1349.
11. Moses W, Weng J, Kebebew E 2011 Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid 21:367-371.
12. Park YJ, Ahn HY, Choi HS, Kim KW, Park do J, Cho BY 2012 The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid 22:356-362.
13. Charkes ND 2006 On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181-186.
14. Loh KC 1997 Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107-113.
15. Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PH, Treseler PA, Weier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH 2000 Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043-1050; discussion 1050-1041.
16. Robenshtok E, Tzvetov G, Grozinsky-Glasberg S, Shraga-Slutzky I, Weinstein R, Lazar L, Serov S, Singer J, Hirsch D, Shimon I, Benbassat C 2011 Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid 21:43-48.
17. Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Shuto S 2002 Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26:897-902.
18. Maxwell EL, Hall FT, Freeman JL 2004 Familial nonmedullary thyroid cancer: a matched-case control study. Laryngoscope 114:2182-2186.
19. Ito Y, Kakudo K, Hirokawa M, Fukushima M, Yabuta T, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A 2009 Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145:100-105.
20. Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F 2008 Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075-1081.
21. Richards ML 2009 Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer. Surg Oncol Clin N Am 18:39-52, viii.
22. Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S 2000 Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286-292.
23. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R 1997 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67.
24. Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T 1997 Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82:2037-2043.
25. Khan A, Smellie J, Nutting C, Harrington K, Newbold K 2010 Familial nonmedullary thyroid cancer: a review of the genetics. Thyroid 20:795-801.
26. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE, Schlumberger M, Romeo G, Canzian F 1999 Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 84:2157-2162.
27. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J, Hoffman L 1997 Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82:345-348.
28. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
29. Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, Sanders K, Kantemiroff T, Bagha S, Goldgar DE, Narod SA, Foulkes WD 2001 Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86:5307-5312.
30. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR, Foulkes WD 1997 Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123-1130.
31. Neumann S, Willgerodt H, Ackermann F, Reske A, Jung M, Reis A, Paschke R 1999 Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Nasymporter. J Clin Endocrinol Metab 84:3750-3756.
32. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM 2000 Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85:1758-1764.
33. Bevan S, Pal T, Greenberg CR, Green H, Wixey J, Bignell G, Narod SA, Foulkes WD, Stratton MR, Houlston RS 2001 A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 86:3701-3704.
34. Cavaco BM, Batista PF, Martins C, Banito A, do Rosario F, Limbert E, Sobrinho LG, Leite V 2008 Familial nonmedullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15:207-215.
35. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998 A gene pre-disposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743-1748.
36. McKay JD, Thompson D, Lesueur F, Stankov K, Pastore A, Watfah C, Strolz S, Riccabona G, Moncayo R, Romeo G, Goldgar DE 2004 Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet 41:407-412.
37. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B, Lacerda M, Martins TC 2008 Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7:141-149.
38. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, Murat A, Kaariainen H, Bertholon-Gregoire M, Zini M, Rossing MA, Toubert ME, Bonichon F, Cavarec M, Bernard AM, Boneu A, Leprat F, Haas O, Lasset C, Schlumberger M, Canzian F, Goldgar DE, Romeo G 2001 Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69:440-446.
39. Stankov K, Pastore A, Toschi L, McKay J, Lesueur F, Kraimps JL, Bonneau D, Gibelin H, Levillain P, Volante M, Papotti M, Romeo G 2004 Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. Int J Cancer 111:463-467.
40. Tomaz RA, Sousa I, Silva JG, Santos C, Teixeira MR, Leite V, Cavaco BM 2012 FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin Endocrinol (Oxf) 77:926-933.
41. Suh I, Filetti S, Vriens MR, Guerrero MA, Tumino S, Wong M, Shen WT, Kebebew E, Duh QY, Clark OH 2009 Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery 146:1073-1080.
42. Capezzone M, Cantara S, Marchisotta S, Filetti S, De Santi MM, Rossi B, Ronga G, Durante C, Pacini F 2008 Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin Endocrinol Metab 93:3950-3957.
43. He M, Bian B, Gesuwan K, Gulati N, Zhang L, Nilubol N, Kebebew E 2013 Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer. Thyroid 23:301-307.
44. Cantara S, Pisu M, Frau DV, Caria P, Dettori T, Capezzone M, Capuano S, Vanni R, Pacini F 2012 Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer. J Clin Endocrinol Metab 97:E1327-E1331.
45. Jendrzejewski J, Tomsic J, Lozanski G, Labanowska J, He H, Liyanarachchi S, Nagy R, Ringel MD, Kloos RT, Heerema NA, de la Chapelle A 2011 Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 96:E1876-E1880.
46. Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J 2000 Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 24:1409-1417.
47. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA, Nikiforov YE 2000 Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290:138-141.
48. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH 1995 Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130:892-897; discussion 898-899.
49. Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H, Sippel RS 2012 In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid 22:3-8.
50. Uchino S, Noguchi S, Yamashita H, Murakami T, Watanabe S, Ogawa T, Tsuno A, Shuto S 2004 Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg 28:1099-1102.
51. Aiken AH 2012 Imaging of thyroid cancer. Semin Ultrasound CT MR 33:138-149.
52. Vriens MR, Sabanci U, Epstein HD, Ngai S, Duh QY, Siperstein AE, Clark OH 1999 Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer. Thyroid 9:1011-1016.
53. Hillenbrand A, Varhaug JE, Brauckhoff M, Pandev R, Haufe S, Dotzenrath C, Koberle R, Hoffmann R, Klein G, Kadmon M, Negele T, Hagieva T, Henne-Bruns D, Luster M, Weber T 2010 Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation. Langenbecks Arch Surg 395:851-858.
54. Triponez F, Wong M, Sturgeon C, Caron N, Ginzinger DG, Segal MR, Kebebew E, Duh QY, Clark OH 2006 Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 30:787-793.
55. Alsanea O, Clark OH 2001 Familial thyroid cancer. Curr Opin Oncol 13:44-51.
56. Xiong Y, Zhang L, Holloway AK, Wu X, Su L, Kebebew E 2011 MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One 6:e24717.
57. Mazeh H 2012 MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules.Oncologist 17:1032-1038.